Suppr超能文献

妊娠早期甲状腺功能减退女性血清中妊娠相关血浆蛋白(PAPP-A)和绒毛膜促性腺激素(β-hCG)的水平

The Levels of Pregnancy-Associated Plasma Protein (PAPP-A) and Chorionic Gonadotropin (β-hCG) in the Blood Serum of Women with Hypothyroidism in the 1st Trimester of Pregnancy.

作者信息

Pasińska Magdalena, Balcerek Emilia, Repczyńska Anna, Łazarczyk Ewelina

机构信息

Department of Clinical Genetics, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Toruń, Poland.

Diagnostic and Medical Centre "Lipowa" Sp. z o. o. in Bydgoszcz, Bydgoszcz, Poland.

出版信息

Int J Womens Health. 2023 Feb 5;15:167-176. doi: 10.2147/IJWH.S386414. eCollection 2023.

Abstract

INTRODUCTION

Hypothyroidism occurs in pregnant women at a rate of 0.3% to 3%. The deficiency of thyroid hormones during pregnancy can lead to an increased risk of pregnancy complications and poor health of the child, particularly affecting its psychomotor development due to the intensive growth of the nervous system during gestation. The study attempted to establish the median concentrations of pregnancy-associated plasma protein PAPP-A and the free subunit of human chorionic gonadotropin β-hCG in women with hypothyroidism in the 1st trimester of pregnancy.

OBJECTIVE

The study attempted to establish the median concentrations of pregnancy-associated plasma protein PAPP-A and the free subunit of human chorionic gonadotropin β-hCG in women with hypothyroidism in the 1st trimester of pregnancy.

PATIENTS AND METHODS

The study included 210 pregnant women between 11 and 13.6 weeks of pregnancy; 105 women were diagnosed with hypothyroidism before or during pregnancy, and 105 women of a similar body weight and gestational age had normal thyroid function.The measurements of the pregnancy parameters studied were performed using the DELFIA Xpress system.

RESULTS

Differences in the multiples of the median of the PAPP-A and β-hCG levels between women with hypothyroidism and healthy women were observed.

CONCLUSION

Introducing correction for patients with hypothyroidism during non-invasive biochemical prenatal testing may allow obtaining more reliable results that would be the basis for referral to invasive procedures.

摘要

引言

甲状腺功能减退症在孕妇中的发生率为0.3%至3%。孕期甲状腺激素缺乏会增加妊娠并发症的风险,并影响胎儿健康,尤其是由于孕期神经系统的快速发育,会对其精神运动发育产生影响。该研究试图确定妊娠早期甲状腺功能减退症女性中妊娠相关血浆蛋白PAPP - A和人绒毛膜促性腺激素β - hCG游离亚基的中位数浓度。

目的

该研究试图确定妊娠早期甲状腺功能减退症女性中妊娠相关血浆蛋白PAPP - A和人绒毛膜促性腺激素β - hCG游离亚基的中位数浓度。

患者与方法

该研究纳入了210名妊娠11至13.6周的孕妇;其中105名女性在怀孕前或孕期被诊断为甲状腺功能减退症,另外105名体重和孕周相似的女性甲状腺功能正常。所研究的妊娠参数测量采用DELFIA Xpress系统进行。

结果

观察到甲状腺功能减退症女性与健康女性之间PAPP - A和β - hCG水平中位数倍数的差异。

结论

在无创生化产前检测期间对甲状腺功能减退症患者进行校正,可能会获得更可靠的结果,这些结果将作为转诊至侵入性检查的依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53da/9911902/372111c27460/IJWH-15-167-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验